Willis Johnson & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-14,050
Closed -$341K – 204
2025
Q4
$341K Hold
14,050
– – 0.02% 131
2025
Q3
$342K Hold
14,050
– – 0.02% 129
2025
Q2
$341K Hold
14,050
– – 0.02% 118
2025
Q1
$340K Hold
14,050
– – 0.03% 112
2024
Q4
$337K Hold
14,050
– – 0.03% 109
2024
Q3
$342K Hold
14,050
– – 0.03% 116
2024
Q2
$333K Hold
14,050
– – 0.03% 110
2024
Q1
$334K Hold
14,050
– – 0.03% 109
2023
Q4
$336K Hold
14,050
– – 0.03% 102
2023
Q3
$325K Hold
14,050
– – 0.03% 98
2023
Q2
$330K Sell
14,050
-375
-3% -$8.88K 0.04% 94
2023
Q1
$344K Buy
+14,425
New +$341K 0.04% 88

Other funds holding IBDS

Willis Johnson & Associates's IBDS Position: Q1 2026 in Review

Willis Johnson & Associates sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q1 2026, closing a stake of 14,050 shares — an estimated $341K sold.

Willis Johnson & Associates first reported a position in IBDS in Q1 2023 and held it in 12 quarters. The position peaked at $344K in Q1 2023. 429 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

  • Willis Johnson & Associates reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
  • Willis Johnson & Associates sold 14,050 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $341K.
  • Willis Johnson & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2023 and held it in 12 quarters.
  • Willis Johnson & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $344K in Q1 2023.
  • 429 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on Willis Johnson & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.